CN113456778A - 一种提升能量的组合物及其制备方法 - Google Patents
一种提升能量的组合物及其制备方法 Download PDFInfo
- Publication number
- CN113456778A CN113456778A CN202110910351.6A CN202110910351A CN113456778A CN 113456778 A CN113456778 A CN 113456778A CN 202110910351 A CN202110910351 A CN 202110910351A CN 113456778 A CN113456778 A CN 113456778A
- Authority
- CN
- China
- Prior art keywords
- parts
- ginseng
- effects
- composition
- galangal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 63
- 238000002360 preparation method Methods 0.000 title abstract description 13
- 235000008434 ginseng Nutrition 0.000 claims abstract description 41
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 40
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 40
- 235000007215 black sesame Nutrition 0.000 claims abstract description 29
- 244000062241 Kaempferia galanga Species 0.000 claims abstract description 28
- 235000013421 Kaempferia galanga Nutrition 0.000 claims abstract description 28
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 27
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract description 22
- 238000002156 mixing Methods 0.000 claims abstract description 22
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 21
- 241000005787 Cistanche Species 0.000 claims abstract description 17
- 241000222336 Ganoderma Species 0.000 claims abstract description 17
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 17
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 14
- 239000008158 vegetable oil Substances 0.000 claims abstract description 14
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- 241000208340 Araliaceae Species 0.000 claims description 40
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 18
- 241000209020 Cornus Species 0.000 claims description 17
- 244000197580 Poria cocos Species 0.000 claims description 16
- 238000012545 processing Methods 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 11
- 241000229143 Hippophae Species 0.000 claims description 10
- 240000008397 Ganoderma lucidum Species 0.000 claims description 9
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 9
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 244000141331 Amomum villosum Species 0.000 claims description 7
- 235000012907 honey Nutrition 0.000 claims description 7
- 241000125175 Angelica Species 0.000 claims description 6
- 235000013355 food flavoring agent Nutrition 0.000 claims description 6
- 230000001965 increasing effect Effects 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 59
- 210000003734 kidney Anatomy 0.000 abstract description 39
- 210000004369 blood Anatomy 0.000 abstract description 32
- 239000008280 blood Substances 0.000 abstract description 32
- 239000003814 drug Substances 0.000 abstract description 18
- 230000006870 function Effects 0.000 abstract description 18
- 210000000952 spleen Anatomy 0.000 abstract description 17
- 210000004185 liver Anatomy 0.000 abstract description 15
- 230000001737 promoting effect Effects 0.000 abstract description 14
- 210000002216 heart Anatomy 0.000 abstract description 10
- 230000002633 protecting effect Effects 0.000 abstract description 9
- 239000003921 oil Substances 0.000 abstract description 8
- 235000019198 oils Nutrition 0.000 abstract description 8
- 229940079593 drug Drugs 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 7
- 208000002193 Pain Diseases 0.000 abstract description 6
- 150000001413 amino acids Chemical class 0.000 abstract description 6
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- 230000003647 oxidation Effects 0.000 abstract description 5
- 238000007254 oxidation reaction Methods 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 5
- 229930003231 vitamin Natural products 0.000 abstract description 5
- 235000013343 vitamin Nutrition 0.000 abstract description 5
- 239000011782 vitamin Substances 0.000 abstract description 5
- 229940088594 vitamin Drugs 0.000 abstract description 5
- 235000001188 Peltandra virginica Nutrition 0.000 abstract description 4
- 239000012530 fluid Substances 0.000 abstract description 4
- 210000000936 intestine Anatomy 0.000 abstract description 4
- 230000003908 liver function Effects 0.000 abstract description 4
- 238000010792 warming Methods 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 230000001914 calming effect Effects 0.000 abstract description 3
- 238000003304 gavage Methods 0.000 abstract description 3
- 241000411851 herbal medicine Species 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000005906 menstruation Effects 0.000 abstract description 3
- 241000721047 Danaus plexippus Species 0.000 abstract description 2
- 230000004087 circulation Effects 0.000 abstract description 2
- 230000000857 drug effect Effects 0.000 abstract description 2
- 210000005036 nerve Anatomy 0.000 abstract description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 238000010298 pulverizing process Methods 0.000 abstract description 2
- 230000008093 supporting effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 description 23
- 239000000047 product Substances 0.000 description 19
- 230000002401 inhibitory effect Effects 0.000 description 14
- 244000061520 Angelica archangelica Species 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 10
- 239000000284 extract Substances 0.000 description 10
- 230000009471 action Effects 0.000 description 9
- 230000000144 pharmacologic effect Effects 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 7
- 229930182494 ginsenoside Natural products 0.000 description 7
- 230000001603 reducing effect Effects 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 206010003549 asthenia Diseases 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 229940089161 ginsenoside Drugs 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 239000000341 volatile oil Substances 0.000 description 6
- 235000003935 Hippophae Nutrition 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 230000000202 analgesic effect Effects 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- IQVQXVFMNOFTMU-FLIBITNWSA-N (Z)-ligustilide Chemical compound C1CC=CC2=C1C(=C/CCC)/OC2=O IQVQXVFMNOFTMU-FLIBITNWSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 241000759833 Cornus officinalis Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 208000031975 Yang Deficiency Diseases 0.000 description 4
- IQVQXVFMNOFTMU-DHZHZOJOSA-N Z-ligustilide Natural products C1CC=CC2=C1C(=C/CCC)\OC2=O IQVQXVFMNOFTMU-DHZHZOJOSA-N 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 210000003169 central nervous system Anatomy 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000002110 toxicologic effect Effects 0.000 description 4
- 231100000759 toxicological effect Toxicity 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000010228 Erectile Dysfunction Diseases 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 210000000748 cardiovascular system Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000012259 ether extract Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000007928 intraperitoneal injection Substances 0.000 description 3
- 238000010253 intravenous injection Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 2
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 241001127714 Amomum Species 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- YTZSBJLNMIQROD-SFBCHFHNSA-N Morroniside Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)O[C@@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YTZSBJLNMIQROD-SFBCHFHNSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- 241000222341 Polyporaceae Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 244000000231 Sesamum indicum Species 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 241000234299 Zingiberaceae Species 0.000 description 2
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 2
- 239000009188 angelicae sinensis extract Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 206010013023 diphtheria Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 2
- -1 etc. Natural products 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 230000002964 excitative effect Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- VCCRNZQBSJXYJD-UHFFFAOYSA-N galangin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=CC=C1 VCCRNZQBSJXYJD-UHFFFAOYSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- SQFSKOYWJBQGKQ-UHFFFAOYSA-N kaempferide Chemical compound C1=CC(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 SQFSKOYWJBQGKQ-UHFFFAOYSA-N 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 210000000944 nerve tissue Anatomy 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- GRWFGVWFFZKLTI-UHFFFAOYSA-N α-pinene Chemical compound CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 2
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- LAOVEVDFIVNYLQ-QDQSDLQTSA-N (2s,3r,4s,5r,6r)-2-[[(2r,3r,4s,5r,6s)-6-[[(2r,3s,4s,5s)-3,4-dihydroxy-5-(hydroxymethyl)-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methoxy]-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@](CO)(O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)O2)O)O1 LAOVEVDFIVNYLQ-QDQSDLQTSA-N 0.000 description 1
- YTZSBJLNMIQROD-UHFFFAOYSA-N (4aS)-1c-beta-D-glucopyranosyloxy-6xi-hydroxy-8t-methyl-(4ar,8ac)-5,6,8,8a-tetrahydro-1H,4aH-pyrano[3,4-c]pyran-4-carboxylic acid methyl ester Natural products C12C(C)OC(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O YTZSBJLNMIQROD-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- KMTDMTZBNYGUNX-UHFFFAOYSA-N 4-methylbenzyl alcohol Chemical compound CC1=CC=C(CO)C=C1 KMTDMTZBNYGUNX-UHFFFAOYSA-N 0.000 description 1
- HVDFMKSCPKILEQ-UHFFFAOYSA-N 5-methoxy-2,3-dimethylphenol Chemical compound COC1=CC(C)=C(C)C(O)=C1 HVDFMKSCPKILEQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- UCTWMZQNUQWSLP-UHFFFAOYSA-N Adrenaline Natural products CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 1
- 241000013298 Alpinia <beetle> Species 0.000 description 1
- 244000141218 Alpinia officinarum Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 241001571352 Amomum longiligulare Species 0.000 description 1
- 206010002482 Angiosclerosis Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 241000336291 Cistanche deserticola Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241001117772 Elaeagnaceae Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 241001489091 Ganoderma sinense Species 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- AMBQHHVBBHTQBF-UHFFFAOYSA-N Loganin Natural products C12C(C)C(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O AMBQHHVBBHTQBF-UHFFFAOYSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000308150 Orobanchaceae Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 241000207960 Pedaliaceae Species 0.000 description 1
- 241000228150 Penicillium chrysogenum Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001127637 Plantago Species 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 208000022329 Protein metabolism disease Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- LUSZGTFNYDARNI-UHFFFAOYSA-N Sesamol Natural products OC1=CC=C2OCOC2=C1 LUSZGTFNYDARNI-UHFFFAOYSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-UHFFFAOYSA-N Sesamolin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-UHFFFAOYSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-AFHBHXEDSA-N Sesamolin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-AFHBHXEDSA-N 0.000 description 1
- LAOVEVDFIVNYLQ-OMMQBQFASA-N Sesamose Natural products O(C[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H](O)[C@@H](O)[C@@](O[C@@H]3[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O3)(CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 LAOVEVDFIVNYLQ-OMMQBQFASA-N 0.000 description 1
- 235000009367 Sesamum alatum Nutrition 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- HEYZWPRKKUGDCR-QBXMEVCASA-N Swertiamarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](C=C)[C@]2(O)CCOC(=O)C2=CO1 HEYZWPRKKUGDCR-QBXMEVCASA-N 0.000 description 1
- HEYZWPRKKUGDCR-WRMJXEAJSA-N Swertiamarin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1[C@@H](C=C)[C@@]2(O)C(C(=O)OCC2)=CO1 HEYZWPRKKUGDCR-WRMJXEAJSA-N 0.000 description 1
- 241001540751 Talaromyces ruber Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241001480050 Trichophyton violaceum Species 0.000 description 1
- 241000009298 Trigla lyra Species 0.000 description 1
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 229940102884 adrenalin Drugs 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- XUEHVOLRMXNRKQ-KHMAMNHCSA-N alpha cubebene Natural products CC(C)[C@@H]([C@H]12)CC[C@@H](C)[C@]32[C@@H]1C(C)=CC3 XUEHVOLRMXNRKQ-KHMAMNHCSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229960000212 aminophenazone Drugs 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000000703 anti-shock Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 229940115397 bornyl acetate Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- CCRCUPLGCSFEDV-UHFFFAOYSA-N cinnamic acid methyl ester Natural products COC(=O)C=CC1=CC=CC=C1 CCRCUPLGCSFEDV-UHFFFAOYSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- XUEHVOLRMXNRKQ-HKGGGCDWSA-N cubebene Chemical compound CC(C)[C@H]([C@@H]12)CC[C@H](C)C32C1C(C)=CC3 XUEHVOLRMXNRKQ-HKGGGCDWSA-N 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- CIPSYTVGZURWPT-UHFFFAOYSA-N galangin Natural products OC1=C(Oc2cc(O)c(O)cc2C1=O)c3ccccc3 CIPSYTVGZURWPT-UHFFFAOYSA-N 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- 229940049654 glyceryl behenate Drugs 0.000 description 1
- 230000002710 gonadal effect Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- AMBQHHVBBHTQBF-UOUCRYGSSA-N loganin Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AMBQHHVBBHTQBF-UOUCRYGSSA-N 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000008897 memory decline Effects 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- CCRCUPLGCSFEDV-BQYQJAHWSA-N methyl trans-cinnamate Chemical compound COC(=O)\C=C\C1=CC=CC=C1 CCRCUPLGCSFEDV-BQYQJAHWSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- SUYJZKRQHBQNCA-UHFFFAOYSA-N pinobanksin Natural products O1C2=CC(O)=CC(O)=C2C(=O)C(O)C1C1=CC=CC=C1 SUYJZKRQHBQNCA-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000028527 righting reflex Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- NCTHNHPAQAVBEB-WGCWOXMQSA-M sodium ferulate Chemical compound [Na+].COC1=CC(\C=C\C([O-])=O)=CC=C1O NCTHNHPAQAVBEB-WGCWOXMQSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- QZZGJDVWLFXDLK-UHFFFAOYSA-N tetracosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(O)=O QZZGJDVWLFXDLK-UHFFFAOYSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于中草药技术领域，公开了一种提升能量的组合物及其制备方法。该组合物是以肉苁蓉为君药，补肾助阳、润肠生津；灵芝补气安神，净化血液，保护肝功能；山茱萸补益肝肾，收敛固涩，固体强身；当归补血调经、保护肾脏、抗氧化；人参大补元气，补脾益肺，上述为臣药，以性温入肝经之效，补肾固阳，补血亏提气；佐以沙棘提高免疫力；砂仁温中行气；高良姜散寒止痛，贯引全方；茯苓和黑芝麻健脾宁心，补益精血，富含大量氨基酸和多种维生素，促进营养成分的吸收能力。该制备方法利用植物油短时加热温度与各中草药原料进行混合，将所有原料粉碎后再次融入油剂中，保证了成品药效，无任何毒副作用，成品符合有效成分含有量低于小鼠灌胃LD50标准量。
Description
技术领域
本发明属于中草药技术领域，具体涉及一种提升能量的组合物及其制备方法。
背景技术
现代人们由于工作压力大，生活压力大，工作和生活中随时需要精力旺盛来解决很多事情。然而随着节奏加快，人们机体均出现了各种各样的问题。
由于肾虚引起精力下降是现有生活中最为普遍的现象。肾虚指肾脏精气阴阳不足。肾虚的种类有很多，其中最常见的是肾阴虚，肾阳虚。肾虚的症状：肾阳虚的症状为腰酸、四肢发冷、畏寒，甚至还有水肿，为“寒”的症状，性功能不好也会导致肾阳虚；肾阴虚的症状为“热”，主要有腰酸、燥热、盗汗、虚汗、头晕、耳鸣等。现代科学证明，当人发生肾虚时，无论肾阴虚还是肾阳虚，都会导致人的免疫能力的降低，有更多的证据表明，肾虚发生时，肾脏的免疫能力降低，而肾脏的微循环系统亦会发生阻塞，肾络呈现不通。所以对于肾虚的治疗应防治结合。
肾虚的症状在脑力方面表现为：记忆力下降记忆力减退，注意力不集中，精力不足，工作效率降低。肾虚的症状在情志方面表现为：情绪不佳情绪常难以自控，头晕，易怒，烦躁，焦虑，抑郁等。肾虚的症状在意志方面表现为：缺乏自信信心不足，缺乏自信，工作没热情，生活没激情，没有目标和方向。
目前，市场上用于补肾、提升能量的药物或是保健品有很多，但是大多数药物的效果并不是很好，并且大多数药物的副作用较多，会对人体健康造成伤害，保健品虽有一定的效果，但是其价格高昂，并且对于使用者来说吸收率不够。
发明内容
为了解决现有技术存在的上述问题，本发明目的在于提供一种提升能量的组合物及其制备方法。
本发明所采用的技术方案为：一种提升能量的组合物，所述组合物主要由以下质量份数的原料制备得到：
肉苁蓉10-15份，灵芝6-12份，山茱萸5-10份，当归6-12份，人参3-10份，沙棘3-9份，砂仁3-6份，高良姜3-6份，茯苓10-15份和黑芝麻9-15份。
肉苁蓉，中药名。为列当科肉苁蓉属植物肉苁蓉Cistanche deserticola Y.C.Ma带鳞叶的肉质茎。具有补肾助阳，润肠通便的功效。主治肾阳亏虚，精血不足，阳痿早泄，宫冷不育，腰膝酸痛，痿软无力，肠燥津枯便秘。味甘、咸，性温；归肾、大肠经。
灵芝，中药名。为多孔菌科灵芝属真菌赤芝Ganoderma lucidum(Leyss.ex Fr.)Karst.或紫芝Ganoderma sinense Zhao，Xu et Zhang的干燥子实体。具有补气安神，止咳平喘的功效。主治心神不宁，失眠，惊悸，咳喘痰多，虚劳证等。味甘，性平；归心、肺、肝、肾经。化学成分本品含多糖、核苷类、呋喃类、甾醇类、生物碱、三萜类、油脂类、多种氨基酸及蛋白质类、酶类、有机锗及多种微量元素等。药理作用灵芝多糖具有免疫调节、降血糖、降血脂、抗氧化、抗衰老及抗肿瘤作用；三萜类化合物能净化血液，保护肝功能；灵芝多种制剂分别具有镇静、抗惊厥、强心、抗心律失常、降压、镇咳平喘作用；此外，灵芝还有抗凝血、抑制血小板聚集及抗过敏作用。毒理作用灵芝毒性较小，小鼠腹腔注射赤芝渗漉液LD50为38.3±1.04g/kg，赤芝热醇提取液腹腔注射，小鼠的LD50为6.75g/kg，灌胃的MLD为165g/kg，冷醇提取液毒性更小，每日给大鼠灌胃1.2g/kg及12g/kg，共30天，对生长发育、肝功能、心电图等均无中毒表现。
山茱萸，中药名。为山茱萸科山茱萸属植物山茱萸Cornus officinalis Sieb.etZucc.的干燥成熟果肉。具有补益肝肾，收敛固涩的功效。主治腰膝酸软，头晕耳鸣，阳痿，遗精滑精，遗尿尿频，崩漏，月经过多，大汗不止，体虚欲脱。味酸、涩，性微温；归肝、肾经。化学成分：果实含山茱萸苷、乌索酸、莫罗忍冬苷、7-0-甲基莫罗忍冬苷、獐牙菜苷、番木鳖苷。此外，还有没食子酸、苹果酸、酒石酸、原维生素A，以及皂苷、鞣质等。药理作用：1、抗病原微生物作用：山茱萸煎剂在体外能抑制金黄色葡萄球菌生长，从鲜果肉中得到的酸味液体对伤寒、痢疾杄菌有抑制作用，水浸剂在试管内对堇色毛癣菌有不同程度的抑制作用。2、对免疫系统的影响：不同剂量山茱萸均能显著升高小鼠血清IgG的含量。并对DNCB所致的接触性皮炎表现出明显的抑制作用。3、对物质代谢的影响：山茱萸有明显的对抗肾上腺素性高血糖的作用，能升高肝糖原。从山茱萸乙醚提取剂中分离制得的乌索酸可以明显地降低血糖和尿糖。4、对心血管系统的影响：动物实验证明，山茱萸可使休克动物血压回升，心搏波振幅增大，具有抗休克作用。5、对血液系统的影响：山茱萸能降低高血糖大鼠的全血比黏度。并能抑制血小板聚集。6、此外，山茱萸尚有一定的利尿、抗炎、抗癌、抗氧化、抗衰老等作用。毒理作用：毒性不大，对兔胃粘膜能引起轻度充血。
当归，中药名。为伞形科当归属植物当归Angelica sinensis(Oliv)Diels.的根。具有补血调经，活血止痛，润肠通便的功效。主治血虚萎黄，月经不调，经闭痛经，血虚、血滞、血寒诸痛，跌打损伤，风湿痹痛，痈疽疮疡，肠燥便秘等。味甘、辛，性温；归肝、心、脾经。化学成分：当归中含β-蒎烯、α-蒎烯、莰烯等中性油成分。含对-甲基苯甲醇、5-甲氧基-2，3-二甲苯酚等酸性油成分、有机酸、糖类、维生素、氨基酸等。药理作用：1、对生殖系统的影响：当归具有双向调节子宫平滑肌的作用。对离体子宫主要起抑制作用，而对在体子宫主要起兴奋作用。2、对心血管系统的影响：当归流浸膏具有抗心肌缺血的作用，当归中性油对心肌缺血亦有保护作用。还具有抗心律失常的作用。当归浸膏具有扩张冠脉、增加冠脉血流量的作用。3、对血液系统的影响：当归粉具有降血脂、对动脉硬化的主动脉病变有一定的保护作用。当归提取物中藁本内酯有抑制血小板聚集的作用。当归及其阿魏酸有明显的抗血栓作用。当归多糖具有促进造血功能的作用。4、对免疫系统的影响：当归总酸既有提高细胞免疫功能的作用，又有促进体液免疫的作用。当归多糖也具有免疫增强作用。5、对中枢神经系统的影响：当归中有效成分藁本内酯具有抑制中枢神经系统的作用当归具有镇痛作用，强于氨基比林，且急性毒性极低6、抗病原微生物的作用：当归所含对体外痢疾、伤寒、副伤寒、大肠杆菌、白喉杆菌、霍乱弧菌及α、β溶血性链球菌等均有抗菌作用；7、对呼吸系统的影响：当归成分藁本内酯具有平喘的作用。8、此外，当归还有保肝、抗肿瘤、抗辐射、抗炎、保护肾脏、抗氧化、纠正蛋白质代谢紊乱等作用。毒理作用：当归毒性小，小鼠静脉注射当归的LD50为80-100g/kg；挥发油皮下注射和灌胃LD50分别为298mg/kg和96mg/kg；藁本内酯腹腔注射的LD50为520mg/kg；阿魏酸钠静脉注射和灌胃的LD50分别为1.7g/kg和3.6g/kg。犬静脉注射当归2g/kg，连续14d，对肝、肾、心电图及血象均无明显影响。5％当归膳食饲养小鼠，经3-5月动物生长健壮，肝脏氧化谷氨酸的能力显著提高。
人参，中药名。为五加科人参属植物人参Panax ginseng C.A.Mey.的根。具有大补元气，补脾益肺，生津，安神益智的功效。主治气虚欲脱，脉微欲绝，脾气不足，中气下陷，肺虚喘咳，气短乏力，津伤口渴，虚热消渴，失眠健忘，心悸怔忡，血虚萎黄，阳痿宫冷等。味甘、微苦，性微温；归肺、脾、心经。化学成分：本品含多种人参皂苷、挥发油、氨基酸、微量元素及有机酸、糖类、维生素等成分。药理作用：1、对神经系统的影响：人参能调节中枢神经系统兴奋过程和抑制过程的平衡，表现为小剂量兴奋中枢神经系统，大剂量则抑制中枢神经系统。2、改善脑组织代谢的作用：人参不但能改善大脑的兴奋过程而且也能改善其抑制过程，使两个过程恢复平衡。人参皂苷Rb、Rg对神经组织具有保护作用，对神经组织的生长和神经网络的建立具有促进作用。3、对记忆获得障碍的影响：人参对学习记忆的影响有双相性和成分依赖性。4、对垂体一肾上腺皮质系统的影响：人参有促进垂体一肾上腺皮质系统功能的作用。5、对心血管系统的影响：人参对多种动物心脏均有先兴奋后抑制，小量兴奋，大量抑制的作用。人参小剂量升压，大剂量降压。人参皂苷具有抗心律失常、保护心肌、降血脂、抗动脉硬化、扩张血管等作用。6、调节免疫功能的作用：人参皂苷可促进网状内皮系统吞噬功能，增加小鼠血清非特异性抗体的浓度。7、对血液系统的影响：人参或其提取物对骨髓的造血功能有刺激和保护作用，具有增强造血功能的作用。人参皂苷具有抑制血小板聚集的作用。8、抗菌作用：人参提取浓缩液对福氏痢疾杄菌la型、乙型溶血性链球菌、产紫青霉菌均有抑制作用。较高浓度对金黄色葡萄球菌、大肠艾氏杄菌、炭疽杄菌、肺炎球菌、黑色曲霉菌、产黄青霉菌有抑制作用。9、此外，人参尚有一定的促进性腺功能、促进蛋白质合成、抗肿瘤、抗氧化、抗衰老、抗肝损伤、抗胃溃疡、抗疲劳、抗应激、抗辐射、抗突变、止血等作用。毒理作用：药理研究表明，人参及有效成分毒性均很小，动物实验皆可耐受很高的剂量。人参根粉小鼠灌胃给药的LD50大于5g/kg以上。人参浸膏小鼠皮下注射给药的LD50为16.5mg/kg。人参提取物或人参皂甙腹腔注射LD50在300-700mg/kg之间。人参皂甙单体对小鼠腹腔注射的LD50分别为：Rb1 1110mg/kg，Rb2 305mg/kg，Rc410mg/kg，Rd 325mg/kg，Re 465mg/kg，Rf1340mg/kg，Rg1 1258mg/kg，Ro＞1000mg/kg。人参多肽对小鼠静脉注射的LD50为1.62g/kg。
沙棘，中药名。为胡颓子科沙棘属植物沙棘Hippophae rhamnoides L.的干燥成熟果实。具有健脾消食，止咳祛痰，活血祛瘀的功效。主治脾虚食少，咳嗽痰多，瘀血证。味甘、酸，性温；归脾、胃、肺经。化学成分：本品含维生素类(C、VA、VE、VB1、VB2、VB12、VK)及叶酸；黄酮类及萜类；蛋白质及多种氨基酸；脂肪及脂肪酸；糖类。此外，尚含生物碱、香豆素及酸性物质，并富含矿物质和微量元素。药理作用：沙棘黄酮能改善心肌微循环，降低心肌耗氧量，抗血管硬化，抗炎等作用；沙棘油及其果汁有抗疲劳、降血脂、抗辐射、抗溃疡、保肝及增强免疫功能等作用。
砂仁，中药名。为姜科砂仁属植物阳春砂Amomum villosum Lour.、绿壳砂Amomumvillosum Lour.var.xanthioides T.L.Wu et Senjen或海南砂Amomum longiligulareT.L.Wu的干燥成熟果实。具有化湿行气，温中止泻，安胎的功效。主治脾胃气滞、湿阻中焦，脾胃虚寒、呕吐泻泄，胎动不安、妊娠恶阻等。味辛，性温；归脾、胃、肾经。化学成分：阳春砂含挥发油，油中主要成分为右旋樟脑、龙脑、乙酸龙脑酯、柠檬烯、橙花叔醇等，并含皂苷。缩砂含挥发油，油中主要成分为樟脑、一种萜烯等。药理作用：1、对胃肠平滑肌的作用：砂仁煎剂可增强胃的功效，促进消化液的分泌，可增进肠道运动，排出消化管内的积气。2、抗血小板凝集作用：砂仁能明显抑制因ADP所致家兔血小板聚集，对花生四烯酸诱发的小鼠急性死亡有明显保护作用，同时有明显的对抗由胶原和肾上腺素所诱发的小鼠急性死亡作用。3、抗溃疡作用：砂仁可显著减少大鼠胃酸分泌。4、镇痛作用：醋酸扭体实验法表明本品有明显的镇痛作用，并能显著减少小鼠抗体细胞数。
高良姜，中药名。为姜科山姜属植物高良姜Alpinia officinarum Hance的干燥根茎。具有散寒止痛，温中止呕的功效。主治胃寒冷痛，胃寒呕吐。味辛，性热；归脾、胃经。化学成分：含挥发油0.5％-1.5％，油中主要成分为1，8-桉叶素、桂皮酸甲酯、丁香油酚、蒎烯、荜澄茄烯及辛辣成分高良姜酚等。尚含黄酮类高良姜素、山柰素、山柰酚、槲皮素、异鼠李素等。药理作用：本品水提取物具有镇痛抗炎作用，醚提物只有镇痛作用，二者均能抗动物实验性胃溃疡的形成及蓖麻油引起的腹泻，还能延长断头小鼠张口动作持续时间和氰化钾中毒小鼠的存活时间；煎剂灌胃能升高犬胃液总酸排出量，兴奋兔离体肠管运动，对抗因阿托品所致小鼠胃肠抑制后的墨汁推进率；采用体内血栓形成法，给大鼠灌胃高良姜水提物或挥发油均有抗血栓形成的作用；100％煎液对炭疽杆菌、α-或β-溶血性链球菌、白喉及类白喉杆菌、肺炎球菌、金黄色葡萄球菌、白色葡萄球菌等革兰阳性嗜气菌皆有抗菌作用。毒理作用：醚提取物小鼠灌胃的LD50为4.2土0.4ml/kg，中毒表现为翻正反射消失，持续8h以上才死亡。小鼠灌服水提取物120g/kg，观察7d，无死亡。高良姜能使鼠伤寒沙门菌TA98和TA100发生诱变。
茯苓，中药名。为多孔菌科卧孔属真菌茯苓Poriacocos(Schw.)Wolf的干燥菌核。产云南者称“云苓”，质较优。具有利水消肿，渗湿，健脾，宁心的功效。主治水肿，痰饮，脾虚泄泻，心悸，失眠。味甘、淡，性平；归心、肺、脾经。
黑芝麻，中药名。为胡麻科芝麻属植物芝麻Sesamum indicum L.的黑色种子。具有补益精血，润燥滑肠的功效。主治须发早白，头晕眼花，妇女产后乳少，风痹，血虚津枯，肠燥便秘等。味甘，性平；归肝、肾、大肠经。化学成分：种子含脂肪油，为油酸、亚油酸、棕榈酸、硬脂酸、花生酸、二十四烷酸、二十二烷酸的甘油酯、芝麻素、芝麻林素、芝麻酚、维生素E，植物甾醇、卵磷脂、叶酸，尚含脂麻苷、蛋白质，车前糖、芝麻糖、磷，钾，细胞色素、多量草酸钙。药理作用：1、抗衰老作用：黑芝麻可使衰老现象推迟发生，肝脏和睾丸中脂褐质水平降低，而血浆中维生素E含量增高。2、抑制肾上腺皮质功能：黑芝麻油0.2mg/100g，可增加肾上腺中维生素C及胆甾醇的含量，肾上腺皮质功能受到某种程度的抑制。3、降血糖作用：黑芝麻种子提取物，可降低血糖，并增加肝糖元及肌糖元含量，但大剂量应用则降低糖元含量。4、兴奋子宫的作用：黑芝麻全草水提取物对子宫有兴奋作用。5、消炎的作用：新鲜灭菌的麻油涂布皮肤黏膜，有减轻刺激、促进炎症恢复等作用。6、降胆固醇的作用：所含亚油酸可降低血中胆固醇含量。7、此外，黑芝麻油有增加血细胞容积倾向、滋养、通便、抑制不饱和脂肪酸酶、芝麻素对不饱和脂酸酶有抑制作用。
作为优选地，所述组合物主要由以下质量份数的原料制备得到：
肉苁蓉11-14份，灵芝7-10份，山茱萸6-8份，当归7-10份，人参4-8份，沙棘4-7份，砂仁3.5-5份，高良姜3.5-5份，茯苓11-14份和黑芝麻10-14份。
作为优选地，所述组合物主要由以下质量份数的原料制备得到：
肉苁蓉13份，灵芝8份，山茱萸7份，当归8份，人参6份，沙棘5份，砂仁4份，高良姜4份，茯苓13份和黑芝麻13份。
一种提升能量的组合物的制备方法，包括按照相应比例选取当归、人参、沙棘、砂仁、高良姜和黑芝麻混合置于加热的溶剂中进行炮制，炮制完成后捞出当归、人参、沙棘、砂仁、高良姜和黑芝麻与肉苁蓉、灵芝、山茱萸、茯苓混合粉碎后，再次置于上述炮制完成后备用的溶剂中，混匀，加入调味剂，造粒，获得成品。
作为优选地，所述溶剂为植物油。
作为优选地，所述溶剂的质量与当归、人参、沙棘、砂仁、高良姜和黑芝麻的总质量比为3-6:0.5-1。
作为优选地，所述加热温度为50-60摄氏度。
作为优选地，所述炮制时长为3-4分钟。
作为优选地，所述当归、人参、沙棘、砂仁、高良姜和黑芝麻与肉苁蓉、灵芝、山茱萸、茯苓混合粉碎，粒径为1200-2500目；
所述调味剂为蜂蜜；
所述调味剂与所有原料的质量比为0.2-0.5:1。
作为优选地，所述成品为丸剂。
本发明的有益效果为：
本发明提供了一种提升能量的组合物，该组合物是以肉苁蓉为君药，味甘、咸，性温；入肾、大肠经，具有补肾助阳、润肠生津的功效；灵芝味甘，性平；归心、肺、肝、肾经，补气安神，净化血液，保护肝功能；山茱萸味酸、涩，性微温；归肝、肾经，补益肝肾，收敛固涩，固体强身；当归味甘、辛，性温；归肝、心、脾经，补血调经、保护肾脏、抗氧化；人参大补元气，补脾益肺，生津，安神益智，上述为臣药，以性温入肝经之效，补肾固阳，补血亏提气；佐以沙棘提高免疫力，抗疲劳；砂仁温中行气；高良姜散寒止痛，贯引全方；茯苓和黑芝麻健脾宁心，补益精血，提升气力，同时富含大量氨基酸和多种维生素，促进营养成分的吸收能力。
该制备方法中通过利用植物油的短时加热中的温度与各中草药原料进行混合，能够通过油剂与各原料中的有效成分进行良好的融合，提高了有效成分的析出与产品中有效成分的含有量。当将所有原料粉碎后再次融入油剂中，进一步保证了成品的使用药效，无任何毒副作用，成品符合有效成分含有量低于小鼠灌胃LD50标准量。
具体实施方式
下面结合具体实施例对本发明做进一步阐释。本领域技术人员将会理解，下列所描述的实施例是本发明一部分实施例，而不是全部的实施例，仅用于说明本发明，而不应视为限制本发明的范围。所用试剂均为可以通过市售购买获得的常规产品。
实施例1：
一种提升能量的组合物的制备方法，包括按照相应比例选取当归6克、人参3克、沙棘3克、砂仁3克、高良姜3克和黑芝麻9克混合置于加热至50摄氏度的植物油162克中进行炮制4分钟，炮制完成后捞出当归、人参、沙棘、砂仁、高良姜和黑芝麻与肉苁蓉10克、灵芝6克、山茱萸5克、茯苓10克混合粉碎过1200目滤筛后，再次置于上述炮制完成后备用的植物油中，混匀，加入蜂蜜29克，造粒，获得成品。
实施例2：
一种提升能量的组合物的制备方法，包括按照相应比例选取当归12克、人参10克、沙棘9克、砂仁6克、高良姜6克和黑芝麻15克混合置于加热至60摄氏度的植物油348克中进行炮制3分钟，炮制完成后捞出当归、人参、沙棘、砂仁、高良姜和黑芝麻与肉苁蓉15克、灵芝12克、山茱萸10克、茯苓15克混合粉碎过2500目滤筛后，再次置于上述炮制完成后备用的植物油中，混匀，加入蜂蜜22克，造粒，获得成品。
实施例3：
一种提升能量的组合物的制备方法，包括按照相应比例选取当归7克、人参4克、沙棘4克、砂仁3.5克、高良姜3.5克和黑芝麻10克混合置于加热至50摄氏度的植物油192克中进行炮制4分钟，炮制完成后捞出当归、人参、沙棘、砂仁、高良姜和黑芝麻与肉苁蓉11克、灵芝7克、山茱萸6克、茯苓11克混合粉碎过1200目滤筛后，再次置于上述炮制完成后备用的植物油中，混匀，加入蜂蜜13.5克，造粒，获得成品。
实施例4：
一种提升能量的组合物的制备方法，包括按照相应比例选取当归10克、人参8克、沙棘7克、砂仁5.5克、高良姜5克和黑芝麻14克混合置于加热至60摄氏度的植物油297克中进行炮制3分钟，炮制完成后捞出当归、人参、沙棘、砂仁、高良姜和黑芝麻与肉苁蓉14克、灵芝10克、山茱萸8克、茯苓14克混合粉碎过2500目滤筛后，再次置于上述炮制完成后备用的植物油中，混匀，加入蜂蜜19.1克，造粒，获得成品
实施例5：
一种提升能量的组合物的制备方法，包括按照相应比例选取当归8克、人参6克、沙棘5克、砂仁4克、高良姜4克和黑芝麻13克混合置于加热至50摄氏度的植物油240克中进行炮制4分钟，炮制完成后捞出当归、人参、沙棘、砂仁、高良姜和黑芝麻与肉苁蓉13克、灵芝8克、山茱萸7克、茯苓13克混合粉碎过2500目滤筛后，再次置于上述炮制完成后备用的植物油中，混匀，加入蜂蜜16.2克，造粒，获得成品。
服用方式：成品为蜜丸颗粒，每粒1g，含服，利用口腔内分泌的酶来逐渐将药物中的成分进行分解和吸收，每日不超过10g。
本发明不局限于上述可选的实施方式，任何人在本发明的启示下都可得出其他各种形式的产品，均属于本发明的保护范围。上述具体实施方式不应理解成对本发明的保护范围的限制，本领域的普通技术人员应当理解，在不背离本发明的范围下，可对前述各实施例所记载的技术方案进行修改，或对其中部分或者全部技术特征进行等同替换，与此同时这些修改或者替换，并不会使相应的技术方案的本质脱离本发明各实施例技术方案的范围。
Claims (10)
1.一种提升能量的组合物，其特征在于，所述组合物主要由以下质量份数的原料制备得到：
肉苁蓉10-15份，灵芝6-12份，山茱萸5-10份，当归6-12份，人参3-10份，沙棘3-9份，砂仁3-6份，高良姜3-6份，茯苓10-15份和黑芝麻9-15份。
2.根据权利要求1所述的一种提升能量的组合物，其特征在于，所述组合物主要由以下质量份数的原料制备得到：
肉苁蓉11-14份，灵芝7-10份，山茱萸6-8份，当归7-10份，人参4-8份，沙棘4-7份，砂仁3.5-5份，高良姜3.5-5份，茯苓11-14份和黑芝麻10-14份。
3.根据权利要求2所述的一种提升能量的组合物，其特征在于，所述组合物主要由以下质量份数的原料制备得到：
肉苁蓉13份，灵芝8份，山茱萸7份，当归8份，人参6份，沙棘5份，砂仁4份，高良姜4份，茯苓13份和黑芝麻13份。
4.一种如权利要求1-3任一所述的提升能量的组合物的制备方法，其特征在于，包括按照相应比例选取当归、人参、沙棘、砂仁、高良姜和黑芝麻混合置于加热的溶剂中进行炮制，炮制完成后捞出当归、人参、沙棘、砂仁、高良姜和黑芝麻与肉苁蓉、灵芝、山茱萸、茯苓混合粉碎后，再次置于上述炮制完成后备用的溶剂中，混匀，加入调味剂，造粒，获得成品。
5.根据权利要求4所述的一种提升能量的组合物的制备方法，其特征在于，所述溶剂为植物油。
6.根据权利要求5所述的一种提升能量的组合物的制备方法，其特征在于，所述溶剂的质量与当归、人参、沙棘、砂仁、高良姜和黑芝麻的总质量比为3-6:0.5-1。
7.根据权利要求4所述的一种提升能量的组合物的制备方法，其特征在于，所述加热温度为50-60摄氏度。
8.根据权利要求4所述的一种提升能量的组合物的制备方法，其特征在于，所述炮制时长为3-4分钟。
9.根据权利要求4所述的一种提升能量的组合物的制备方法，其特征在于，所述当归、人参、沙棘、砂仁、高良姜和黑芝麻与肉苁蓉、灵芝、山茱萸、茯苓混合粉碎，粒径为1200-2500目；
所述调味剂为蜂蜜；
所述调味剂与所有原料的质量比为0.2-0.5:1。
10.根据权利要求4所述的一种提升能量的组合物的制备方法，其特征在于，所述成品为丸剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110910351.6A CN113456778A (zh) | 2021-08-09 | 2021-08-09 | 一种提升能量的组合物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110910351.6A CN113456778A (zh) | 2021-08-09 | 2021-08-09 | 一种提升能量的组合物及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113456778A true CN113456778A (zh) | 2021-10-01 |
Family
ID=77867714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110910351.6A Pending CN113456778A (zh) | 2021-08-09 | 2021-08-09 | 一种提升能量的组合物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113456778A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115006506A (zh) * | 2022-05-30 | 2022-09-06 | 张翔 | 一种滋补养肾的人参制剂及其制备方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1081370A (zh) * | 1992-07-22 | 1994-02-02 | 李高霖 | 一种保健液的生产方法及其产品 |
| CN101164565A (zh) * | 2006-10-18 | 2008-04-23 | 武彪 | 治疗须发少白、中年早白、脱发的特效中药膏剂及制备方法 |
| CN106615477A (zh) * | 2017-01-22 | 2017-05-10 | 新乡市人分九种健康管理有限公司 | 一种具有温肾补气功能的复方代用茶及其制备方法 |
| CN107050182A (zh) * | 2017-01-15 | 2017-08-18 | 崔悦 | 白二仙正雄丸 |
| CN113332390A (zh) * | 2021-07-09 | 2021-09-03 | 北京贡源本草生物科技有限公司 | 一种补肝肾的中药组合物及其制备方法 |
-
2021
- 2021-08-09 CN CN202110910351.6A patent/CN113456778A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1081370A (zh) * | 1992-07-22 | 1994-02-02 | 李高霖 | 一种保健液的生产方法及其产品 |
| CN101164565A (zh) * | 2006-10-18 | 2008-04-23 | 武彪 | 治疗须发少白、中年早白、脱发的特效中药膏剂及制备方法 |
| CN107050182A (zh) * | 2017-01-15 | 2017-08-18 | 崔悦 | 白二仙正雄丸 |
| CN106615477A (zh) * | 2017-01-22 | 2017-05-10 | 新乡市人分九种健康管理有限公司 | 一种具有温肾补气功能的复方代用茶及其制备方法 |
| CN113332390A (zh) * | 2021-07-09 | 2021-09-03 | 北京贡源本草生物科技有限公司 | 一种补肝肾的中药组合物及其制备方法 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115006506A (zh) * | 2022-05-30 | 2022-09-06 | 张翔 | 一种滋补养肾的人参制剂及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104799146A (zh) | 一种改善亚健康的功能性营养食品组合及其制备方法 | |
| CN101612315A (zh) | 一种用于调整人体机能的中药复方制剂 | |
| CN105942498A (zh) | 具有治疗糖尿病作用的功能性营养食品组合及其制备方法 | |
| CN101543248A (zh) | 一种特别适合“三高一酸”人群饮用的凉茶及其制备方法 | |
| KR102192573B1 (ko) | 생리통 및 피부 트러블의 예방 및 개선용 조성물 | |
| CN1319403A (zh) | 一种治疗过敏性紫癜病的药 | |
| CN103142848B (zh) | 一种抗衰老中药制剂及其制备方法 | |
| CN113456778A (zh) | 一种提升能量的组合物及其制备方法 | |
| KR20160000695A (ko) | Dha 함유 기억력 강화 및 피로회복 증진용 한약재 조성물 수능환 및 그 제조방법 | |
| CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
| CN110538308B (zh) | 一种生发的中药组合物及其制备方法 | |
| CN111298020B (zh) | 具有抗疲劳功效的中药组合物及其制备方法与应用 | |
| CN1329049C (zh) | 降血糖、降血压的药物 | |
| CN108813500B (zh) | 具有补中益气、养血安神和调节人体机能的养生蜂蜜膏 | |
| CN102266427A (zh) | 一种用于美容养颜的鹿茸当归酒及其制备方法和应用 | |
| CN101669995A (zh) | 一种用于心脑血管疾病治疗和保健的组合物及其制备方法 | |
| CN101828703B (zh) | 一种增强机体免疫力并能改善睡眠质量的产品及制备方法 | |
| CN101816708B (zh) | 治疗风湿病的中药组合物及其制备方法 | |
| CN105055691A (zh) | 一种高效克服高龄男性勃起功能障碍的中药组合物 | |
| CN116942763B (zh) | 一种滋阴健脾中药组合物、压片糖果及制备方法和应用 | |
| CN107233490A (zh) | 一种益气养阴美容养颜的玛咖组合物 | |
| CN116474039B (zh) | 一种激发人体潜能提高男性性功能的中药组合物及其制备方法与应用 | |
| CN103110675A (zh) | 改善营养性贫血软胶囊及其制备方法 | |
| CN108452079B (zh) | 延缓衰老抑制肿瘤细胞生长及改善微循环的方法和组合物 | |
| CN111388563B (zh) | 一种用于预防新生儿母乳性黄疸的组合物及其制备方法和应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211001 |
|
| RJ01 | Rejection of invention patent application after publication |